CSIMarket


Eli Lilly And Company  (LLY)
Other Ticker:  
 

Eli Lilly And Company

LLY's Fundamental analysis








Looking into Eli Lilly growth rates, revenue grew by 14.76 % in I. Quarter 2022 from the same quarter a year ago. Ranking at No. 1538

Major Pharmaceutical Preparations industry recorded growth of revenues by 19.45 %

Eli Lilly's net income grew by 40.4 % in I. Quarter 2022 year on year, above company average,

More on LLY's Growth


Eli Lilly
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Eli Lilly PEG ratio is at 51 Eli Lilly realized cash outflow of $ -0.6per share in trailing twelve-month period.
Company
45.39
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 9.46.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.39.


More on LLY's Valuation
 
 Total Debt (Millions $) 16,509
 Dividend TTM ($) 3.51 $
 Dividend Yield TTM (%) 1.28 %
 Revenue/Employee (TTM) $ 872,054
 Net Income/Employee (TTM) $ 182,284
 Receivable Turnover (TTM) 4.74
 Tangible Book Value (Per Share $) -2.11

Eli Lilly
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Eli Lilly PEG ratio is at 51 Eli Lilly realized cash outflow of $ -0.6per share in trailing twelve-month period.
Company
45.39
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 9.46.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.39.

Eli Lilly Price to Book Ratio is at 29.31 lower than Indusry Avg. of 1306. and higher than S&P 500 Avg. of -0.01

More on LLY's Valuation

  Market Capitalization (Millions $) 277,322
  Shares Outstanding (Millions) 906
  Employees 33,625
  Revenues (TTM) (Millions $) 29,323
  Net Income (TTM) (Millions $) 6,129
  Cash Flow (TTM) (Millions $) -543
  Capital Exp. (TTM) (Millions $) -1,375
  Total Debt (Millions $) 16,509
  Dividend TTM ($) 3.51 $
  Dividend Yield TTM (%) 1.28 %
  Revenue/Employee (TTM) $ 872,054
  Net Income/Employee(TTM) $ 182,284
  Receivable Turnover Ratio (TTM) 4.74
  Tangible Book Value (Per Share $) -2.11

  Market Capitalization (Millions $) 277,322
  Shares Outstanding (Millions) 906
  Employees 33,625
  Revenues (TTM) (Millions $) 29,323
  Net Income (TTM) (Millions $) 6,129
  Cash Flow (TTM) (Millions $) -543
  Capital Exp. (TTM) (Millions $) -1,375


    LLY's Profitability Comparisons
Eli Lilly achieved increase in profitability, due to cost control. Operating Margin grew in I. Quarter 2022 to 30.78 % from 23.97 % in IV. Quarter.

Eli Lilly net profit margin of 24.36 % is currently ranking no. 22 in Major Pharmaceutical Preparations industry, ranking no. 48 in Healthcare sector and number 737 in S&P 500.


Profitability by Segment



  Ratio
   Capital Ratio (MRQ) 2.56
  Total Debt to Equity (MRQ) 1.74
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.61
  Inventory Turnover Ratio (TTM) 1.94



Eli Lilly achieved increase in profitability, due to cost control. Operating Margin grew in I. Quarter 2022 to 30.78 % from 23.97 % in IV. Quarter.

Eli Lilly net profit margin of 24.36 % is currently ranking no. 22 in Major Pharmaceutical Preparations industry, ranking no. 48 in Healthcare sector and number 737 in S&P 500.

More on LLY's Key Ratios



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

TRAQ's Profile

Stock Price

TRAQ's Financials

Business Description

Fundamentals

Charts & Quotes

TRAQ's News

Suppliers

TRAQ's Competitors

Customers & Markets

Economic Indicators

TRAQ's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071